Investigation of the Effect of Date Consumption on Hedonic Hunger and Appetite in Adult Individuals With Type 2 Diabetes
Recruiting now · Not applicable
Conditions studied: Type 2 Diabetes Mellitus, Appetite
In brief
The aim of this study was to investigate the effects of date consumption on hedonic hunger and appetite hormones in individuals diagnosed with type 2 diabetes.The main questions it aims to answer are: * Does date consumption reduce hedonic hunger in individuals with type 2 diabetes? * Does persimmon consumption change Ghrelin, GLP-1 and GIP concentrations in individuals with Type 2 diabetes? * Does persimmon consumption reduce HOMA-IR and HbA1c values in individuals with Type 2 diabetes? * Does consumption of persimmon reduce LDL cholesterol, total cholesterol and triglyceride concentrations in individuals with type 2 diabetes? To see the effects of date consumption on hedonic hunger and appetite hormones, the researchers will compare individuals with type 2 diabetes who consume 3 dates daily with individuals with type 2 diabetes who do not. Participants: * Individuals in the intervention group will consume 3 (25 g) Baghdad dates (15 g CHO) daily as part of the breakfast meal, while individuals in the control group will not consume dates. * Three interviews will be conducted with patients. * A record of blood findings and questionnaires will be kept during these interviews.
Key facts
- Study ID
- NCT06826235
- Run by
- Hacettepe University
- People needed
- 64
- Starts
- 2024-05-14
- Expected to finish
- 2025-03-01
- Last updated by the study team
- 2025-02-13
Who can join
Age: 19 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Individuals diagnosed with Type 2 diabetes aged 19-50 years (excluding menopausal women),
- Individuals with BMI between 25-35 kg/m2,
- Individuals with a Nutritional Strength Scale score of 2.5 and above,
- Individuals who agreed not to start taking new dietary supplements or alternative therapies during the study period,
- Individuals who agree not to change their current physical activity level and diet.
You may not qualify if…
- Individuals who do not approve the volunteer consent form,
- Individuals with a Nutritional Strength Scale score below 2.5,
- Pregnant or breastfeeding women (or women planning to become pregnant within 3 months)
- Individuals with dietary energy <800 kcal/day and >4000 kcal/day,
- Individuals with pre-diabetes, type 1 diabetes and gestational diabetes,
- Individuals with HbA1c >10
- Individuals taking antibiotics or hormone replacement therapy History of malignancy (except non-melanoma skin cancer).
- Individuals with regular consumption of dates before inclusion in the study,
- Individuals diagnosed with Type 2 diabetes using insulin and oral antidiabetic drugs with thiazolidinedione active substance,
- Individuals with a history of diabetic ketoacidosis, diabetic coma or precoma within 6 months prior to the date of admission; serious infections, surgery, serious trauma requiring insulin treatment, haemodialysis treatment (including peritoneal haemodialysis), serious liver injury and serious vascular complications (stroke, myocardial infarction and heart failure) requiring hospitalisation,
- Individuals taking pharmacological agents that have effects on appetite such as psychotropics, antiepileptics, antidepressants, antipsychotics and/or steroids,
- Individuals diagnosed with eating disorders and/or psychological disorders,
- Individuals with physical illnesses that affect eating behaviour or appetite, such as uncontrolled hyperthyroidism or hypothyroidism, Cushing's disease, acromegaly, adrenal insufficiency, chronic renal failure (stage 4 or 5), tuberculosis, human immunodeficiency virus (HIV) infection.
Where it is running
- Erzurum City Hospital — Erzurum, Palandöken, Turkey (Türkiye) (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.